[{"NetIncomeLoss_1_Q1_USD":28300000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":10200000.0,"MarketableSecuritiesCurrent_0_Q1_USD":899000000.0,"OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_1_Q1_USD":200000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":45000000.0,"TreasuryStockCommonShares_0_Q1_shares":26619216.0,"InterestPaidNet_1_Q1_USD":4000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-16800000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_0_Q1_USD":829100000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-6300000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":10200000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":500000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":165000000.0,"AssetsCurrent_0_Q1_USD":2014300000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":1800000.0,"OtherNoncashIncomeExpense_1_Q1_USD":8500000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":559000000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":23000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":200000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":17500000.0,"ProceedsFromSaleOfTradingSecuritiesHeldforinvestment_1_Q1_USD":108900000.0,"EquitySecuritiesFvNi_0_Q1_USD":66300000.0,"CommonStockSharesIssued_0_Q1_shares":71407834.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":31200000.0,"LongTermLineOfCredit_0_Q1_USD":800000000.0,"TreasuryStockCommonValue_0_Q1_USD":2579200000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-2900000.0,"Liabilities_0_Q1_USD":1195600000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":5500000.0,"EarningsPerShareBasic_1_Q1_USD":0.63,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":454400000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-2900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":46400000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":97200000.0,"AccountsReceivableNetCurrent_0_Q1_USD":141100000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":4200000.0,"CommonStockValue_0_Q1_USD":700000.0,"RepaymentsOfLinesOfCredit_1_Q1_USD":0.0,"ProceedsFromIncomeTaxRefunds_1_Q1_USD":1600000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":2266200000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-25000000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.13,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":10100000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_0_Q1_USD":832700000.0,"CostsAndExpenses_1_Q1_USD":443900000.0,"GainOnSaleOfInvestments_1_Q1_USD":91900000.0,"OtherAssetsCurrent_0_Q1_USD":49700000.0,"IncreaseDecreaseInInventories_1_Q1_USD":2200000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":25700000.0,"OtherAssetsNoncurrent_0_Q1_USD":171200000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":832300000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":2173200000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":12500000.0,"Assets_0_Q1_USD":4641000000.0,"ShareBasedCompensation_1_Q1_USD":40100000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":317200000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-2600000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":9600000.0,"Goodwill_0_Q1_USD":28000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":32500000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":10200000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":14400000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":89800000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":16000000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1_Q1_USD":0.0,"EquityMethodInvestmentRealizedGainLossOnDisposal_1_Q1_USD":91900000.0,"EarningsPerShareDiluted_1_Q1_USD":0.61,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":44600000.0,"LiabilitiesCurrent_0_Q1_USD":302400000.0,"NonoperatingIncomeExpense_1_Q1_USD":97300000.0,"InterestExpense_1_Q1_USD":4600000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":832300000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_1_Q1_USD":2800000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":17500000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":2800000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":5100000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":713700000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":1433500000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":303700000.0,"CommonStockSharesOutstanding_0_Q1_shares":44788618.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-16300000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":263600000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"GoodwillGross_0_Q1_USD":28000000.0,"CommonStockSharesAuthorized_0_Q1_shares":245000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":379100000.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q1_USD":17000000.0,"OperatingIncomeLoss_1_Q1_USD":-64800000.0,"InventoryNet_0_Q1_USD":92200000.0,"InvestmentIncomeInterest_1_Q1_USD":4700000.0,"PreferredStockValue_0_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":4641000000.0,"AssetImpairmentCharges_1_Q1_USD":17000000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":41100000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":1030900000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":93200000.0,"OtherLiabilitiesCurrent_0_Q1_USD":30300000.0,"StockholdersEquity_0_Q1_USD":3445400000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":10600000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":0.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":2257100000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q1_USD":44700000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":3867500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":93600000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":40100000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-300000.0,"Ticker":"UTHR","CIK":"1082554","name":"UNITED THERAPEUTICS CORP","OfficialName":"United Therapeutics Corporation Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"8315138472.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210505"}]